CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
A

HIV infection

Inflammatory & ImmuneDisease / conditionrisknon modifiable
44
evidence score

Also known as: hiv-positive, human immunodeficiency virus, people living with hiv

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 17.8meta-analyses: 11.6trials: 14.3genetic: 0MR bonus:

References (59)

3 meta-analyses / systematic reviews

Clinical trials (26)

NCTTitleStatusTypeInterventions
NCT04725617Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive AdultsRECRUITINGINTERVENTIONALVarenicline, Smoking Cessation Counseling, Health Approach 1 to Reduce Smoking
NCT06739915TUTT-PT: Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South AfricaCOMPLETEDINTERVENTIONALTUTT-PT Intervention
NCT06403787Effect of Implementing an Aerobic Training Program and Administering Ginkgo Biloba Extract on Plasma Concentrations of LDL and HDL in HIV Positive Patients Undergoing Antiretroviral Treatment at the HIV Unit of Hospital Civil Fray Antonio AlcaldeCOMPLETEDINTERVENTIONALAerobic exercise + Ginkgo Biloba Extract, Aerobic exercise + Calcined magnesia (placebo), Aerobic exercise + Atorvastatin
NCT05168137Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral TherapyUNKNOWNINTERVENTIONALLow-dose colchicine, Placebo
NCT03500302Effect of Evolocumab on Coronary Endothelial FunctionCOMPLETEDINTERVENTIONALEvolocumab
NCT03207945Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)COMPLETEDINTERVENTIONALAlirocumab, Placebo
NCT02833844A Double Blind, Randomized, Placebo Controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy on LDL-C of Evolocumab (AMG 145) in Subjects With HIV and With Hyperlipidemia and/or Mixed DyslipidemiaCOMPLETEDINTERVENTIONALEvolocumab, Placebo
NCT02841774High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With Human Immunodeficiency Virus (HILLCLIMBER)COMPLETEDINTERVENTIONALPravastatin, Rosuvastatin
NCT02624180Inflammatory Pathogenesis of Coronary Atherosclerosis in HIVCOMPLETEDINTERVENTIONALColchicine, Placebo
NCT02810275Effect of Folic Acid on Homocysteine Levels and Flow-mediated Dilation in HIV and HIV-HCV Coinfected Patients: a Randomized Controlled TrialCOMPLETEDINTERVENTIONALFolinic Acid, Placebo
NCT01041521The Impact of Omega Three Fatty Acids on Vascular Function in HIVCOMPLETEDINTERVENTIONALLovaza
NCT00857298Effect of Diet-induced Weight Loss on HIV-associated Metabolic SyndromeCOMPLETEDINTERVENTIONALDietary Intervention
NCT00795717Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) TrialCOMPLETEDINTERVENTIONALLovaza, Placebo
NCT00665717The Influence of Raltegravir on Pravastatin Pharmacokinetics in Healthy Volunteers (GRAPPA)COMPLETEDINTERVENTIONALPravastatin, Raltegravir, Pravastatin and raltegravir
NCT00986986Prospective Randomized Pilot Study of the Effect of Niaspan on Endothelial Function in HIV-infected Subjects With Low HDL Cholesterol LevelsCOMPLETEDINTERVENTIONALextended release niacin
NCT00264394Efficacy of a Computerised Physician Reminder System to Control Cardiovascular Risk Factors in HIV-infected Patients Receiving Antiretroviral Therapy: A Nested Randomised Controlled Cluster Trial Within the Swiss HIV Cohort StudyCOMPLETEDINTERVENTIONALUpdated CHD risk profiles, Guidelines
NCT00405171Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia: A Randomized Controlled StudyCOMPLETEDINTERVENTIONALNevirapine
NCT05881447Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in a Primary Care Setting in Semirural Sub-Saharan AfricaRECRUITINGOBSERVATIONAL
NCT07662161Coronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study)NOT YET RECRUITINGOBSERVATIONALSimple coronary CT scan
NCT05563116Coronary Artery Calcium Score in People Living With HIV: the French HIV-CAC Cohort StudyCOMPLETEDOBSERVATIONALComputed tomography coronary artery calcium (CAC) score (part of routine workup)
NCT00918073Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Infected PatientsCOMPLETEDOBSERVATIONAL
NCT00381992Risk Assessment of Long-Haul Truck DriversCOMPLETEDOBSERVATIONAL
NCT03416257Gut Microbial-related Choline Metabolite Trimethylamine-N-oxide is Associated With Progression of Carotid Artery Atherosclerosis in HIV InfectionCOMPLETEDOBSERVATIONALNo intervention
NCT01519141Immunologic and Inflammatory Factors and Cardiovascular Risk in Patients With HIV Infection or Autoimmune DiseasesCOMPLETEDOBSERVATIONAL
NCT00253682Cardiac Status of HAART Exposed Infants of HIV-Infected Mothers (CHAART I)COMPLETEDOBSERVATIONAL
NCT00001102Metabolic Consequences of Highly Active Antiretroviral Therapy (HAART) in HIV-Positive IndividualsCOMPLETEDOBSERVATIONAL

Genetic associations (0)

None linked.